stoxline Quote Chart Rank Option Currency Glossary
PAVmed Inc. (PAVM)
2.96  0.06 (2.07%)    12-08 15:59
Open: 2.9
High: 3.0199
Volume: 81,614
Pre. Close: 2.9
Low: 2.75
Market Cap: 27(M)
Technical analysis
2023-12-08 4:45:17 PM
Short term     
Mid term     
Targets 6-month :  4.09 1-year :  4.77
Resists First :  3.5 Second :  4.09
Pivot price 0.61
Supports First :  1.46 Second :  0.2
MAs MA(5) :  1.32 MA(20) :  0.51
MA(100) :  0.35 MA(250) :  0.41
MACD MACD :  0.3 Signal :  0.1
%K %D K(14,3) :  59.6 D(3) :  50.6
RSI RSI(14): 95.6
52-week High :  3.5 Low :  0.2
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ PAVM ] has closed above the upper band by 14.5%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 1777% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 1 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 3.02 - 3.03 3.03 - 3.05
Low: 2.72 - 2.73 2.73 - 2.75
Close: 2.94 - 2.96 2.96 - 2.98
Company Description

PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay. Its product pipeline also comprises EsoCure, an esophageal ablation device to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; NextFlo, a disposable infusion platform technology; Veris cancer healthcare platform and implantable intelligent vascular port combining remote monitoring and data analytics; NextVent single-use ventilators; FlexMO medical circulatory support cannulas; Veris cardiac monitors; DisappEAR resorbable pediatric ear tubes; Solys noninvasive glucose monitoring. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.

Headline News

Thu, 07 Dec 2023
Shareholders in PAVmed (NASDAQ:PAVM) have lost 88%, as stock drops 30% this past week - Simply Wall St

Mon, 04 Dec 2023
PAVmed announces dividend of Lucid Diagnostics shares and reverse stock split - Seeking Alpha

Mon, 04 Dec 2023
PAVmed Announces Dividend of Lucid Diagnostics Common Stock and Reverse Stock Split - PR Newswire

Mon, 20 Nov 2023
PAVmed Inc. (NASDAQ:PAVM) Q3 2023 Earnings Call Transcript - Yahoo Finance

Thu, 16 Nov 2023
2023-11-16 | NDAQ:PAVM | Press Release | PAVmed Inc - Stockhouse Publishing

Mon, 13 Nov 2023
2023-11-13 | NDAQ:PAVM | Press Release | PAVmed Inc - Stockhouse Publishing

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Medical Devices
Shares Out -30 (M)
Shares Float 0 (M)
Held by Insiders 1.2076e+008 (%)
Held by Institutions 1.137e+008 (%)
Shares Short 0 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS -3.24e+006
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -0.7
Profit Margin 0 %
Operating Margin -1 %
Return on Assets (ttm) 963 %
Return on Equity (ttm) -84 %
Qtrly Rev. Growth 358 %
Gross Profit (p.s.) 0
Sales Per Share -590.33
EBITDA (p.s.) -4.10127e+006
Qtrly Earnings Growth -7.392e+007 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)
Stock Valuations
PE Ratio -0.01
PEG Ratio 0
Price to Book value -4.23
Price to Sales -0.01
Price to Cash Flow 0
Stock Dividends
Dividend 3.27e+006
Forward Dividend 3.66e+006
Dividend Yield 110473000%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android